cerinib capsule
drug international ltd., squib road - ceritinib - capsule - 150 mg
erinlar capsule
genvio pharma ltd. - ceritinib - capsule - 150 mg
zykadia 150 mg capsule
novartis pharma ag, switzerland - ceritinib - capsule - 150 mg
zykadia 150 mg capsule capsule, hard
novartis pharma ag, switzerland - ceritinib - capsule, hard - 150 mg
alkon capsule
techno drugs ltd. - ceritinib - capsule - 150 mg
zykadia tablets 150mg (ジカディア錠150mg)
novartis pharma k.k. - ceritinib - light blue tablets, diameter: 9.1 mm, thickness: 3.9 mm
paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.
lorviqua
pfizer europe ma eeig - lorlatinib - carcinoma, non-small-cell lung - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor.lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.
norvir
abbvie deutschland gmbh co. kg - ritonavir - hiv infections - antivirals for systemic use, - ritonavir is indicated in combination with other antiretroviral agents for the treatment of hiv-1-infected patients (adults and children of two years of age and older).,
paxlovid (nirmatrelvir 150 mg film-coated tablets and ritonavir 100 mg film-coated tablets)
pfizer (malaysia) sdn. bhd. - nirmatrelvir; ritonavir -